Lupus: Open Access
Open Access
ISSN: 2684-1630
ISSN: 2684-1630
Yves Renaudineau
Immunotherapy Graft Oncology, Innovative Medicines Initiative PRECISESADS, Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France
Dr. Renaudineau's research interests include the role of B cells in the pathophysiology of systemic lupus erythematosus, Sjögren's syndrome and chronic lymphocytic leukemia, with a special focus on CD5 molecule, calcium flux and DNA methylation due to their interconnections. As part of the research group EA2216 Immunology, Pathology and Immunotherapy, Brest University Medical School in France, he has been one of the pioneers to consider the importance of DNA methylation in SLE B cells, and the key role played by the CD5 molecules in chronic lymphocytic leukemia. His research group currently focuses on the investigation of regulatory B cell functions, calcium flux, epigenetics and the effects of B cell therapies on these processes.
Dr. Renaudineau is full Professor of Immunology and has published more than 90 original papers in leading journals such as Blood, Cancer Research, Arthritis Rheum, J Immunol, J Autoimmun, etc.
Systemic lupus erythematosus, sjogren's syndrome, chronic lymphocytic leukemia, Pathology, Immunotherapy